Recent reports on Mstn knock out (Mstn−/−) mice or treatment with myostatin antagonists (e.g. soluble activin type IIB receptor) showed resistance to develop obesity in response to high-fat diet (e.g. [16]). Here, MSTN is linked to obesity disorder.